STAAR Surgical Company (STAA) has a 30-year history specializing in products for ophthalmic surgery and vision correction; first, for the treatment of cataracts going back to 1991, and the introduction of its revolutionary 'implantable contact lenses' marketed as Visian ICL in 1996. The stock surged over the past year as the company reported accelerating sales, particularly from Asia, and a pipeline for new products to address various different vision issues. The company just reported Q1 earnings beating both top line and EPS estimates with overall strong operational results. On the other hand, the company disclosed